Literature DB >> 22495187

Acute kidney injury in children.

A Merouani1, O Flechelles, P Jouvet.   

Abstract

Acute kidney injury (AKI) affects 5% of critically ill hospitalized children and is a risk factor for increased morbidity and mortality. The current review focuses on new definitions of acute kidney injury, standardized to reflect the entire spectrum of the disease, as well as on ongoing research to identify early biomarkers of kidney injury. Its also provides an overview of current practice and available therapies, with emphasis on new strategies for the prevention and pharmacological treatment of diarrhea-associated hemolytic uremic syndrome. Furthermore, a decision-making algorithm is presented for the use of renal replacement therapies in critically ill children with AKI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495187

Source DB:  PubMed          Journal:  Minerva Pediatr        ISSN: 0026-4946            Impact factor:   1.312


  3 in total

1.  Molecular Absorbent Recirculating System therapy (MARS®) in pediatric acute liver failure: a single center experience.

Authors:  Pierre Bourgoin; Aicha Merouani; Véronique Phan; Catherine Litalien; Michel Lallier; Fernando Alvarez; Philippe Jouvet
Journal:  Pediatr Nephrol       Date:  2013-12-06       Impact factor: 3.714

Review 2.  Acute kidney injury due to bilateral ureteral obstruction in children.

Authors:  Daniele Bianchi; Giuseppe Vespasiani; Pierluigi Bove
Journal:  World J Nephrol       Date:  2014-11-06

3.  Renal replacement therapy in adult and pediatric intensive care : Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD).

Authors:  Christophe Vinsonneau; Emma Allain-Launay; Clarisse Blayau; Michael Darmon; Damien Ducheyron; Theophile Gaillot; Patrick M Honore; Etienne Javouhey; Thierry Krummel; Annie Lahoche; Serge Letacon; Matthieu Legrand; Mehran Monchi; Christophe Ridel; René Robert; Frederique Schortgen; Bertrand Souweine; Patrick Vaillant; Lionel Velly; David Osman; Ly Van Vong
Journal:  Ann Intensive Care       Date:  2015-12-30       Impact factor: 6.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.